Search results for " mellitus"

showing 10 items of 2078 documents

Prevalence of diabetes mellitus and impaired glucose tolerance in cystic fibrosis.

1990

The aim of this study was to evaluate the prevalence of impaired glucose tolerance or diabetes mellitus in 99 patients (53 M, 46 F; mean age 10.5 +/- 6.9 years), with cystic fibrosis. Glucose tolerance was evaluated in all patients without overt diabetes using the oral glucose tolerance test (OGTT). Six patients showed a pathological OGTT and 2 patients had insulin-requiring diabetes mellitus. The mean age of the patients with impaired glucose tolerance was significantly higher than that of the subjects with normal glucose metabolism (p less than 0.0001). Patients with overt diabetes mellitus were the oldest subjects in the study group.

AdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesAdolescentCystic FibrosisEndocrinology Diabetes and MetabolismStatistics as TopicCarbohydrate metabolismGastroenterologyCystic fibrosisImpaired glucose toleranceEndocrinologyInternal medicineDiabetes mellitusEpidemiologyInternal MedicinemedicineDiabetes MellitusPrevalenceHumansChildPathologicalGlucose tolerance testmedicine.diagnostic_testbusiness.industrynutritional and metabolic diseasesInfantGeneral MedicineGlucose Tolerance Testmedicine.diseaseEndocrinologyChild PreschoolFemalebusinessComplicationActa diabetologica latina
researchProduct

Professional continuous glucose monitoring in subjects with type 1 diabetes: retrospective hypoglycemia detection.

2013

Background: An important task in diabetes management is detection of hypoglycemia. Professional continuous glucose monitoring (CGM), which produces a glucose reading every 5 min, is a powerful tool for retrospective identification of unrecognized hypoglycemia. Unfortunately, CGM devices tend to be inaccurate, especially in the hypoglycemic range, which limits their applicability for hypoglycemia detection. The objective of this study was to develop an automated pattern recognition algorithm to detect hypoglycemic events in retrospective, professional CGM. Method: Continuous glucose monitoring and plasma glucose (PG) readings were obtained from 17 data sets of 10 type 1 diabetes patients und…

AdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismBiomedical EngineeringBioengineeringHypoglycemiaSensitivity and SpecificityAutomationDiabetes managementBlood Glucose Self-MonitoringDiabetes mellitusInternal MedicineMedicineHumansIntensive care medicineGlycemicMonitoring PhysiologicRetrospective StudiesType 1 diabetesbusiness.industryContinuous glucose monitoringBlood Glucose Self-Monitoringnutritional and metabolic diseasesRetrospective cohort studyMiddle Agedmedicine.diseaseHypoglycemiaDiabetes Mellitus Type 1Original ArticlebusinessAlgorithmsJournal of diabetes science and technology
researchProduct

Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers.

2003

Pharmacokinetic and pharmacodynamic profiles of the rapid-acting insulin analogues lispro and aspart were compared in a randomized, double-blind crossover study of 20 fasting healthy men following a single subcutaneous injection. Either insulin lispro or aspart, 0.05 U/kg-body-weight, was injected subcutaneously and followed by determination of 5-h profiles of plasma glucose, serum C-peptide and insulin concentrations. Lowest glucose concentrations were observed after 50 min in the aspart group (3.2 +/- 0.1 mmol/l versus lispro 3.5 +/- 0.1 mmol/l; p = 0.026) and after 60 min in the lispro group (3.4 +/- 0.1 mmol/l). For blood glucose t min was 59.3 +/- 3.4 min in the aspart and 63.5 +/- 5.3…

AdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentRadioimmunoassayInsulin aspartSubcutaneous injectionEndocrinologyPharmacokineticsDouble-Blind MethodDiabetes mellitusInternal medicineInternal MedicinemedicineInsulin lisproHumansHypoglycemic AgentsInsulinInsulin AspartCross-Over StudiesInsulin LisproC-Peptidebusiness.industryInsulindigestive oral and skin physiologynutritional and metabolic diseasesGeneral Medicinemedicine.diseaseCrossover studyEndocrinologyPharmacodynamicsbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct

Implication of lipids in macrosomia of diabetic pregnancy: can n-3 polyunsaturated fatty acids exert beneficial effects?

2003

Macrosomia or fetal obesity is a frequent complication of pregnancy in diabetes mellitus. Several alterations observed in carbohydrate and lipid metabolism in macrosomic infants of diabetic mothers are thought to be a consequence of maternal hyperglycaemia leading to fetal hyperinsulinaemia. Macrosomic infants of diabetic mothers are prone to the development of glucose intolerance, obesity and diabetes during childhood and adulthood. Furthermore, increasing evidence is accumulating regarding the importance of n-3 polyunsaturated fatty acids (PUFAs) in the reduction of plasma lipids and hyperglycaemia. In this review article, we shed light on the abnormalities in lipid metabolism in macrosom…

AdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesLipoproteinsPregnancy in DiabeticsFetal MacrosomiaPregnancyDiabetes mellitusInternal medicineFatty Acids Omega-3Diabetes MellitusmedicineAnimalsHumansObesitychemistry.chemical_classificationPregnancyFetusbusiness.industryMetabolic disorderInfant NewbornLipid metabolismGeneral MedicineLipid Metabolismmedicine.diseaseObesityGestational diabetesEndocrinologychemistryFemaleInsulin ResistancebusinessPolyunsaturated fatty acidClinical Science
researchProduct

Classical cardiovascular risk factors according to fasting plasma glucose levels

2007

To compare the prevalence of classical cardiovascular risk factors (CVRF) and metabolic syndrome (MetS) in our population according to fasting plasma glucose levels (FPG).We have studied 344 subjects between 20-70 years of age, recruited in a Primary Care Clinic. Subjects were divided into four groups according to their fasting plasma glucose (FPG) values: normal plasma glucose (NG) when FPG5.6 mmol/L; FPG between 5.6 and 6.0 mmol/L (FPG1); FPG between 6.1-6.9 mmol/L (FPG2); and diabetes (DM) FPGor = 7 mmol/L or previous diagnosis of diabetes. Cardiovascular risk factors (hypertension, TC/HDL-C index and Apo B values), presence of the MetS and indirect measure of insulin resistance (HOMA) w…

AdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesPopulationCardiovascular risk factorsComorbiditySeverity of Illness IndexRisk FactorsInternal medicinePrevalenceInternal MedicinemedicineHumanseducationPractical implicationsAgedMetabolic Syndromeeducation.field_of_studyPlasma glucosebusiness.industrynutritional and metabolic diseasesType 2 Diabetes MellitusFastingMiddle AgedImpaired fasting glucosemedicine.diseasePrimary care clinicCross-Sectional StudiesEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesSpainFemaleMetabolic syndromebusinessEuropean Journal of Internal Medicine
researchProduct

A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea

2014

Study objectives Obstructive sleep apnea (OSA) is associated with an increased prevalence of metabolic syndrome (MetS), even in patients with morbid obesity. Our goal was to address whether continuous positive airway pressure (CPAP) treatment improved glucose metabolism in this population. Methods A prospective randomized controlled trial was performed in severe OSA patients with morbid obesity without diabetes in two university referral hospitals. Patients received conservative (CT) versus CPAP treatment for 12 weeks. MetS components, homeostasis model assessment of insulin resistance (HOMA-IR) and oral glucose tolerance were assessed at baseline and after treatment. Results A total of 80 …

AdultBlood GlucoseMalemedicine.medical_specialtyglucose tolerancemedicine.medical_treatmentPopulationSettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematologyImpaired glucose tolerance03 medical and health sciences0302 clinical medicineInsulin resistancePhysiology (medical)Internal medicineDiabetes mellitusinsulin resistanceGlucose IntoleranceWeight LossmedicineHumansInsulinProspective StudiesContinuous positive airway pressureeducationobstructive sleep apneaMetabolic SyndromeSleep Apnea Obstructiveeducation.field_of_studyGlucose tolerance testContinuous Positive Airway Pressuremedicine.diagnostic_testbusiness.industryGlucose Tolerance TestMiddle Agedmedicine.diseaseObesity Morbidrespiratory tract diseasesSurgeryObstructive sleep apnea030228 respiratory systemFemaleNeurology (clinical)Insulin ResistanceMetabolic syndromeSleep Disordered Breathingbusinesscontinuous positive airway pressure
researchProduct

Distribution of HOMA-IR in a population-based cohort and proposal for reference intervals

2021

Abstract Objectives Insulin resistance (IR) is a hallmark of type 2 diabetes mellitus (DM). The homeostatic model assessment of insulin resistance (HOMA-IR) provides an estimate for IR from fasting glucose and insulin serum concentrations. The aim of this study was to obtain a reference interval for HOMA-IR for a specific insulin immunoassay. Methods The Gutenberg Health Study (GHS) is a population-based, prospective, single-center cohort study in Germany with 15,030 participants aged 35–74 years. Fasting glucose, insulin, and C-peptide were available in 10,340 participants. HOMA-IR was calculated in this group and three reference subgroups with increasingly more stringent inclusion criteri…

AdultBlood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryCohort StudiesInsulin resistanceInternal medicineDiabetes mellitusmedicineHumansInsulinProspective StudiesPrediabetesAgedbusiness.industryInsulinBiochemistry (medical)General MedicineMiddle Agedmedicine.diseaseDiabetes Mellitus Type 2CohortHomeostatic model assessmentFemaleInsulin ResistanceMetabolic syndromebusinessCohort studyClinical Chemistry and Laboratory Medicine (CCLM)
researchProduct

Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism.

2003

OBJECTIVE—To identify a reliable yet simple indirect method for detection of insulin resistance (IR). RESEARCH DESIGN AND METHODS—A total of 65 subjects (44 men and 21 women aged 30–60 years) were selected by a simple random sampling method. Inclusion criteria were voluntary participation from staff and hospital personnel, absence of abnormal glucose tolerance, and normal results of lipid profile and basic blood chemistry. A blood sample was taken after a 12-h overnight fast to determine plasma lipid, glucose, and insulin levels. An intravenous glucose tolerance test with administration of insulin after 20 min and extraction of multiple blood samples for glucose and insulin measurements and…

AdultBlood GlucoseMalemedicine.medical_specialtymedicine.medical_treatmentEndocrinology Diabetes and MetabolismCarbohydrate metabolismModels BiologicalInsulin resistanceReference ValuesInternal medicineDiabetes mellitusInternal MedicinemedicineHomeostasisHumansInsulinObesityAdvanced and Specialized NursingGlucose tolerance testSex Characteristicsmedicine.diagnostic_testbusiness.industryInsulinQuantitative insulin sensitivity check indexInsulin sensitivityFastingGlucose Tolerance Testmedicine.diseaseLipidsEndocrinologyClampGlucoseBlood chemistryFemaleMetabolic syndromeInsulin ResistanceLipid profilebusinessDiabetes care
researchProduct

In renal transplanted patients inflammation and oxidative stress are interrelated.

2006

Introduction: The inflammatory state plays a well-documented role to cause oxidative stress, especially in end-stage renal disease (ESRD) patients, wherein several cardiovascular risk factors are amplified by the coexistence of a microinflammatory state with increased oxidative stress. Methods: We measured serum concentrations of high sensitivity C-reactive protein (CRP), tumor necrosis factor α (TNFα), 8-iso-prostaglandin F2α (8-iso-PGF2α-in vivo oxidative stress marker) in 15 chronic renal failure (CRF) and 15 transplant patients versus 15 healthy controls. Exclusion criteria were: age 65 years as well as a diagnosis of diabetes or cardiovascular diseases. We evaluated systolic (SBP) and …

AdultBlood GlucoseMalemedicine.medical_specialtyrenal transplantation oxidative stress inflammationRenal functionInflammationBlood Pressuremedicine.disease_causeWhite PeopleBody Mass Indexchemistry.chemical_compoundDiabetes mellitusInternal medicinemedicineCadaverHumansInflammationTransplantationCreatinineAnalysis of Variancebusiness.industryMiddle Agedmedicine.diseaseKidney TransplantationTissue DonorsOxidative StressBlood pressureEndocrinologyC-Reactive ProteinchemistryItalyKidney Failure ChronicSurgeryTumor necrosis factor alphamedicine.symptombusinessBody mass indexOxidative stressBiomarkersGlomerular Filtration Rate
researchProduct

Physical activity does not inevitably improve quality of life in young adults with type 1 diabetes

2016

Relationships between exercise, glucose control and diabetes dependent quality of life (DDQoL) are not straightforward. We investigated the DDQoL of 99 persons with type 1 diabetes and linked it to individual amount of weekly physical activity and HbA1c. Physically active lifestyle was not associated with better DDQoL or glucose control.

AdultBlood GlucoseMaleyoung adultsmedicine.medical_specialtyquality of life questionnaireGlucose controlEndocrinology Diabetes and MetabolismPhysical activityphysical activity030209 endocrinology & metabolism03 medical and health sciencesYoung Adult0302 clinical medicineEndocrinologyQuality of life (healthcare)Diabetes mellitusSurveys and QuestionnairesInternal MedicinemedicineHumans030212 general & internal medicineYoung adultta315Life StyleRetrospective StudiesGlycated HemoglobinType 1 diabetesexercisebusiness.industryta3141General Medicinemedicine.diseaseDiabetes Mellitus Type 1Physical therapyQuality of LifeFemalebusinessDiabetes Research and Clinical Practice
researchProduct